From the Department of Neurosurgery (H.J.B.), Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Department of Neurosurgery (Y.K.P.), Inje University Ilsan Paik Hospital, Goyang, Korea.
AJNR Am J Neuroradiol. 2021 Jun;42(6):1099-1103. doi: 10.3174/ajnr.A7085. Epub 2021 Apr 29.
The treatment paradigm for very large and giant aneurysms has recently changed to flow diversion, in light of the results of the Pipeline for Uncoilable or Failed Aneurysms trial. However, the effects of flow diversion were definitely unknown. We explored this topic and identified the predictors of such effects.
We retrospectively reviewed 51 patients with unruptured aneurysms admitted to our institution for flow diversion between February 2014 and August 2019. Patients were categorized into an effect group (no filling or remnant entry) and a no-effect group (subtotal or total filling). We evaluated the aneurysm size and shape, incorporation vessel, parent artery stenosis and curvature, stagnation of contrast medium within the aneurysm, use of balloon angioplasty, and intra-aneurysm thrombus as potential predictors of the effects of flow diversion.
The effect group comprised 34 patients (66.7%, 34/51; no filling, 35.3%, 18/51; and remnant entry, 31.4%, 16/51). The no-effect group comprised 17 patients (33.3%, 17/51; subtotal filling, 29.4%, 15/51; and total filling, 3.9%, 2/51). An incorporation vessel and balloon angioplasty were independent risk factors for the no-effect group in multivariate logistic regression analyses (OR = 0.13 and 0.05; 95% confidence intervals, 0.02-0.62 and 0.00-0.32; values, .021 and .004, respectively).
Flow diversion is effective for very large and giant aneurysms, but the outcomes require further improvement. The results of this study show that an incorporated vessel and excessive balloon angioplasty might compromise flow diversion. This finding can help improve the outcomes of flow diversion.
鉴于 Pipeline for Uncoilable or Failed Aneurysms 试验的结果,治疗巨大和巨型动脉瘤的方法最近已经转变为血流导向治疗。然而,血流导向的效果尚不确定。我们探讨了这一课题,并确定了影响血流导向效果的预测因素。
我们回顾性分析了 2014 年 2 月至 2019 年 8 月期间因血流导向治疗而在我院就诊的 51 例未破裂动脉瘤患者。患者分为有效果组(无填充或残余入口)和无效果组(部分或完全填充)。我们评估了动脉瘤的大小和形状、吻合血管、载瘤动脉狭窄和弯曲、瘤内对比剂停滞、球囊血管成形术的使用以及瘤内血栓形成等因素作为血流导向效果的潜在预测因素。
有效果组包括 34 例患者(66.7%,34/51;无填充 35.3%,18/51;残余入口 31.4%,16/51)。无效果组包括 17 例患者(33.3%,17/51;部分填充 29.4%,15/51;完全填充 3.9%,2/51)。在多变量逻辑回归分析中,吻合血管和球囊血管成形术是无效果组的独立危险因素(OR=0.13 和 0.05;95%置信区间,0.02-0.62 和 0.00-0.32; 值,分别为.021 和.004)。
血流导向治疗对巨大和巨型动脉瘤是有效的,但需要进一步改善治疗效果。本研究结果表明,吻合血管和过度球囊血管成形术可能会影响血流导向的效果。这一发现有助于提高血流导向的治疗效果。